Rodrigo Santos Andrade share

Novo Nordisk and Eli Lilly cut obesity drug prices to compete in China | REUTERS

visibility comment0 event December 30, 2025 timer 09:13

Ads

Novo Nordisk and Eli Lilly lowered prices of their leading obesity drugs Wegovy and Mounjaro in China to strengthen their positions in a rapidly expanding market facing rising obesity rates. #News #Reuters #Newsfeed #novonordisk #elililly #obesity #china

Read the story here: https://reut.rs/4jfKOvU

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en

Tags:

No Comments

Leave a Reply

Rihanna Spotted Heading to César Restaurant in Paris After Céline Dion Concert Israeli attacks leave at least 20 dead in Gaza Mormon church shooting in Michigan ICE Shootings Trump wants US military back in Afghanistan US veloes United Nation’s demand for Gaza ceasefire